Physician profile
Mark N Grinzinger
NPI 1376923623
$2,774.59
in general payments reported to CMS, 2019-2025
9 companies · $40.80 in 2025
The $40.80 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $207 · 2021: $981 · 2022: $48.43 · 2023: $1,307 · 2024: $13.54 · 2025: $40.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,147 · Food and Beverage: $122 · Education: $75.00 · Gift: $16.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,147.23 |
| Food and Beverage | $121.88 |
| Education | $75.00 |
| Gift | $16.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $1,178.90 | 2023 | |
| Zimmer Biomet Holdings, INC. | $966.56 | 2021 | |
| Axogen | $334.50 | 2019-2020 | |
| Straumann USA LLC | $111.59 | 2022-2023 | |
| Biohorizons Implant Systems INC. | $76.67 | 2023-2025 | Biohorizons, Biohorizons Dental Implants |
| Tactile Systems Technology INC | $49.37 | 2019 | |
| Depuy Synthes Sales INC. | $25.38 | 2022-2024 | Matrixmandible |
| American Orthodontics Corporation | $16.95 | 2023 | Master Series, Radiance, Empower-Ceramic |
| Nobel Biocare USA | $14.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grinzinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.